Related Experiment Video
Updated: Jul 12, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Update Breast Cancer 2023 Part 2 - Advanced-Stage Breast Cancer
Michael P Lux1, Andreas D Hartkopf2, Tanja N Fehm3
1Klinik für Gynäkologie und Geburtshilfe, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, St. Vincenz Krankenhaus GmbH, Paderborn, Germany.
Abstract:
In recent years, a number of new therapies have led to advances in the treatment of patients with advanced breast carcinoma. These substances are mainly CDK4/6 inhibitors and other substances that can overcome endocrine resistance, oral selective estrogen receptor degraders, antibody drug conjugates (ADCs), and PARP inhibitors. This review summarizes and evaluates the latest study results that have been published in recent months. This includes the overall survival data of the Destiny-Breast03 study, the first analysis of the CAPItello-291 study, the comparison of CDK4/6 inhibitor treatment with chemotherapy in the first line of therapy (RIGHT Choice study), the first analysis of the Destiny-Breast02 study in the treatment setting after T-DM1 treatment, and the first analysis of the Serena-2 study. Most of these studies have the potential to significantly change the therapeutic landscape for patients with advanced breast carcinoma and show that the continued rapid development of new therapies is always producing new results.
Insights
New therapies, including CDK4/6 inhibitors and antibody drug conjugates (ADCs), are improving outcomes for advanced breast cancer patients. Recent studies show significant potential to change treatment paradigms and improve survival rates.
Area of Science:
- Oncology
- Medical Therapeutics
- Clinical Research
Background:
- Advanced breast carcinoma treatment has seen recent therapeutic advancements.
- Key emerging therapies include CDK4/6 inhibitors, oral selective estrogen receptor degraders, antibody drug conjugates (ADCs), and PARP inhibitors.
- These agents aim to overcome endocrine resistance and improve patient outcomes.
Purpose of the Study:
- To review and evaluate recent study results on novel therapies for advanced breast carcinoma.
- To assess the impact of new treatments on the therapeutic landscape.
- To highlight ongoing developments in breast cancer therapy.
Main Methods:
- Review of recently published clinical study results.
- Analysis of overall survival data from key trials.
- Evaluation of treatment comparisons and efficacy in specific settings.
Main Results:
- Destiny-Breast03 study demonstrated significant overall survival data.
- CAPItello-291 and Serena-2 studies presented initial analyses.
- RIGHT Choice study compared CDK4/6 inhibitors with chemotherapy in first-line therapy.
- Destiny-Breast02 study provided first analysis post-T-DM1 treatment.
Conclusions:
- Recent studies indicate significant potential to alter the treatment of advanced breast carcinoma.
- The rapid development of novel therapies continues to yield promising new results.
- These advancements offer new hope and improved therapeutic options for patients.
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

